Alexandria Real Estate Equities stock falls 3.88% and underperforms competitors

6 articles · Updated · MarketWatch · Apr 27

Shares closed at $45.56 on Monday, nearly 48.4% below their 52-week high of $88.24 set in September.
The decline occurred during a mixed trading session, with the S&P 500 rising 0.12% and the Dow Jones falling 0.13%.
Alexandria's stock lagged behind BXP, which rose 0.52%, while Healthpeak and Medical Properties Trust also posted smaller declines.

As Alexandria's stock tumbles, are its competitors poised to capitalize on the market disruption?

Alexandria's stock is down 50% with a 10% dividend. Is it a value trap or a generational buying opportunity?

With the Fed pausing rate cuts, can interest-rate-sensitive REITs like Alexandria actually recover this year?

Blackstone sees a prime entry point for real estate. Does this include the troubled life sciences sector?

With falling occupancy and an investor lawsuit, how will Alexandria navigate the current real estate crisis?

Alexandria's income soared while its cash flow fell. What does this contradiction reveal about its financial health?